|
Gushengtang Holdings Limited is a Chinese healthcare company operating a chain of Traditional Chinese Medicine (TCM) clinics. Founded in 2010, the company provides TCM diagnosis and treatment services through a network of offline medical institutions and online healthcare platforms. Its business model integrates offline clinics with digital services, utilizing AI and internet technologies to enhance patient access and medical resource distribution. The company serves patients in China and Singapore, with recent expansion into Malaysia through the acquisition of Yongsheng TCM Group. Gushengtang collaborates with various TCM hospitals and universities to build medical alliances and cultivate medical talent. The group also develops proprietary TCM formulations and engages in partnerships with technology firms for AI-driven medical applications. Summarised from the company's own disclosures, fiscal year ended Apr 2026 |
Industry Medical Care Facilities | Homepage gstzy.cn |
| Sector Healthcare | IR page www2.gstzy.cn | |
|
Tags
traditional chinese medicine, outpatient care, telemedicine, ai healthcare, medical alliances, tcm formulations, Yongsheng TCM Group, YC TCM SEGAR, YC TCM, SWS Medical, Guangzhou University of Chinese Medicine Gushengtang Branch, Nanjing University of Chinese Medicine Gushengtang Ningxi Outpatient Department, Gushengtang TCM Supply Center
|
Press page gstzy.cn/news/index.html |
Metrics
| Valuation | |
|---|---|
| Market cap | HK$ 6B |
| Market cap (USD) | $ 764.649M |
| P/E | 16.30 |
| PEG | 0.67 |
| P/BV | 2.82 |
| P/S | 1.50 |
| P/OCF | 14.69 |
| P/FCF | — |
| Dividend yield | 6.8% |
| Turnover / mcap | 0.29% |
| Returns | |
|---|---|
| ROE | 15.5% |
| ROI | 15.3% |
| ROIC | 15.3% |
| Profit margin | 10.9% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | 24.4% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | Yes |
| Buying back stock | Yes |
| Diluting (TTM) | No |
| Debt/Equity | 6.2% |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 13 |
| Quality score | 47.1% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements and reports published on HKEXnews, newest first, monthly and next-day returns, proxy forms and board-meeting notices included. The link opens the announcement on HKEXnews. Press releases from the company's own website, newest first.
固生堂中医2026-10-20
10月18日-19日,受固生堂诚挚邀请,国医大师周岱翰教授赴新加坡固生堂参观并开展学术交流。期间,周大师以《中医学是维护人类健康的先进医学和治疗措施》为题作专题授课,来自新加坡、马来西亚的近百名执业中医师参会。固生堂董事长涂志亮全程陪同并出席相关活动。

国医大师周岱翰教授受邀赴新加坡开展学术交流

国医大师周岱翰教授亲临新加坡固生堂Novena Specialist Center诊所参观指导
本次学术会议是固生堂在新加坡举办的中医药临床传承系列讲座之一。固生堂通过邀请国医大师等顶尖专家赴新讲学交流、临床带教,持续搭建高水平学术交流平台,提升海外中医师诊疗水平。
专题授课:周岱翰大师阐释中医学临床优势与慢病管理价值
讲座伊始,固生堂中医集团董事长涂志亮对周岱翰教授的远道莅临致以崇高敬意。他表示,周岱翰教授是曾在美国国立癌症中心(NCI)发表学术演讲的中医泰斗,相关交流促进了中美在中医肿瘤领域的国家级交往,也推动了传统医学体系在麻省理工、哈佛大学等机构的传播。周大师对于推动中医学走向世界医疗体系,并与现代医学形成融合作出了极为重要的贡献。

固生堂中医集团董事长涂志亮致辞
新加坡前卫生与交通部高级政务部长、固生堂海外高级顾问蓝彬明医生在致辞中感谢固生堂搭建了优质的国际学术交流平台,将中国顶尖中医专家的临床经验与学术成果带到新加坡。他表示,中医药是新加坡医疗保健体系的重要补充,随着人口老龄化加剧、慢性病负担持续增加,中医药在健康促进、慢病管理、康复与辅助治疗等领域,拥有巨大的探索价值与应用潜力。他期待通过更多专业研讨、临床协作与科研探索,推动中西医各展所长、互补融合,为患者提供更全面、优质的整合医疗服务。

新加坡前卫生与交通部高级政务部长、固生堂海外高级顾问蓝彬明医生致辞
讲座中,周岱翰教授指出,中医药是兼具文化与医学双重属性的生命科学。中医以“形、气、神”三部一体解读生命本质,依托独具特色的象思维,通过望闻问切四诊合参实现“以外揣内”,洞察人体生理与病理变化。
随着全球疾病谱从急性传染病向慢性非传染病转变,慢病高发成为现实。周岱翰教授认为,治未病、心身并治与促进自愈力,是中医学最为突出的临床优势。他阐释了中医寿命学“调神、养形、治未病、中和”四大核心内涵,倡导以人为本,坚持辨证论治、三因制宜,重视调摄心神,调动人体自组织、自平衡的内在修复力量,并非单纯对抗病邪,而是实现阴阳自和以达自愈,这对肿瘤等复杂慢病管理具有重要现实指导价值。

讲座中,周大师还结合晚期宫颈癌患者长期带瘤生存的真实临床案例,直观诠释中医扶正固本、心身同调的实践成效,为东南亚地区中医从业者提供理论与临床双重启发。
诊所参访:国医大师点赞固生堂国际化实践
10月18日,周岱翰教授还莅临新加坡固生堂Novena Specialist Center诊所参观交流,与固生堂新加坡团队及当地医师深入交流,围绕肿瘤及慢病的中医诊疗思路、疑难病例的辨证等分享专业见解,现场交流气氛热烈。

周岱翰大师亲临新加坡固生堂Novena Specialist Center诊所参观

周岱翰大师与当地医师交流
为期两天的交流中,涂志亮董事长全程陪同参访,并向周大师介绍新加坡多元文化特色、本地医疗环境及固生堂在新加坡的发展布局。周岱翰教授对固生堂的国际化举措表示高度认可,并勉励固生堂及新加坡本地中医师继续守正创新,把中医的整体观、辨证论治优势用好,服务好本地民众的健康需求。
目前,固生堂在新加坡运营28家中医诊所,形成覆盖主要社区与核心医疗区的服务网络。未来,固生堂将继续携手顶尖专家力量,搭建高水平学术交流平台,深化专业交流与跨领域合作,推动中医药在海外的传承、创新与发展,让传统中医智慧在国际舞台上焕发新的活力。

链接复制成功

咨询电话:400-626-7777

公司介绍 | 专家科普 |企业动态 |投资者关系 |人才招聘 |联系我们
集团地址:广东省广州市越秀区东风东路761号丽丰中心35F
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Gushengtang Holdings Limited
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.































